| Financial Year |
March 31 2023 |
| Monetary Funds |
138,679,818.93 |
| Held-for-trading Financial Assets |
106,704,230.00 |
| Notes Receivable |
11,905,481.82 |
| Accounts Receivable |
235,514,900.03 |
| Advances to Suppliers |
28,339,859.35 |
| Other Receivables |
4,906,604.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
404,392,316.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,907,672.44 |
| Total Current Assets |
942,742,541.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
305,249,017.14 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,283,413.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
139,216.61 |
| Deferred Income Tax Assets |
12,604,926.81 |
| Other Non-Current Assets |
97,371,292.25 |
| Sub-Total of Non-Current Assets |
463,853,853.34 |
| Total Assets |
1,406,596,395.27 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
116,792,412.08 |
| Accounts Payable |
140,563,026.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,649,560.58 |
| Taxes Payable |
5,612,555.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
534,545.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,637,229.97 |
| Other Current Liabilities |
13,348,072.04 |
| Sub-Total of Current Liabilities |
473,516,893.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
14,781,660.89 |
| Deferred Income Tax Liabilities |
2,351,336.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,868,386.01 |
| Total Liabilities |
498,385,279.54 |
| Paid-In Capital(Or Share Stock) |
64,000,000.00 |
| Capital Surplus |
555,988,672.62 |
| Surplus Reserve |
4,420,113.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
278,077,675.24 |
| Minority Stockholder's Interest |
1,223.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
908,209,892.67 |
| Owner's Equity（Stockholder's Equity） |
908,211,115.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,406,596,395.27 |
